Cardiometabolic Health in Adolescents of South Asian Ancestry - the CHAriSmA study
南亚血统青少年的心脏代谢健康 - CHARiSmA 研究
基本信息
- 批准号:10190921
- 负责人:
- 金额:$ 66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-04 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:21 year oldAddressAdipocytesAdolescentAdolescent and Young AdultAdultAffectAfricanAfrican AmericanAgeArginineAsian AmericansBangladeshBeta CellBhutanBlood VesselsBody CompositionBody fatBody mass indexCardiovascular DiseasesCell physiologyCell secretionCollaborationsCross-Sectional StudiesDataDepositionDiseaseDyslipidemiasEnvironmental ExposureEthnic OriginEthnic groupEuropeanFatty AcidsFatty acid glycerol estersFree AssociationFutureGenerationsGlucoseHealthHourIndiaIndividualInflammationInsulinInsulin ResistanceInvestigationKineticsLeadLipidsLipoproteinsMagnetic Resonance ImagingMaldivesMeasuresMediatingMetabolicMetabolic DiseasesMethodsMicroRNAsModelingNIH Program AnnouncementsNational Institute of Diabetes and Digestive and Kidney DiseasesNepalNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsOGTTObesityPakistanPathologyPathway interactionsPatternPhysiologic pulsePlant RootsPopulationRequest for ProposalsResearch ProposalsRiskRisk FactorsSouth AmericanSouth AsianSri LankaTechniquesTestingUnited States National Institutes of HealthVisceralVisceral fatabdominal fatadipokinesbasecardiometabolic riskcardiometabolismcardiorespiratory fitnesscardiovascular disorder riskclinical phenotypecomparison groupexpectationexperiencefatty acid metabolismglucose disposalglucose tolerancehealth disparityinflammatory markerinnovationinsightinsulin regulationinsulin secretioninsulin signalinglipid metabolismmathematical modelmultidisciplinarynovelorgan injuryparticleresponsesex
项目摘要
Project Summary/Abstract
South Asians (SA), the fastest growing major ethnic group in the U.S., are also at greater type 2 diabetes (T2DM) and
cardiovascular disease (CVD) risk at relatively lower body mass index (BMI) compared to those of European and African
ancestry. The mechanism(s) underlying this increased cardiometabolic risk remain undefined. We are submitting this
research proposal in response to an NIH program announcement (PA-17-021) requesting proposals addressing health
disparities in NIDDK diseases. The increased cardiometabolic risk in SA Americans represent an understudied and
disparate risk. Mostly adult, associative studies performed outside the U.S. indicate that SA have higher % body fat,
visceral adiposity, and abdominal adiposity for a given BMI than other ethnic groups. These studies have also found
increased insulin resistance and dyslipidemia as well as decreased insulin-mediated glucose disposal (inversely
proportional to visceral fat) and β-cell function in SA adults. We propose to study SA adolescents, in order to elucidate
early mechanistic changes underlying their increased cardiometabolic risk. Given the unique fat distribution of SA, we
propose to define ectopic fat deposition and test for altered fat metabolism and β-cell insulin secretion in SA adolescents
in the U.S. We will use cutting-edge, innovative techniques, including MRI/MRS, mathematical modeling of free fatty
acid (FFA) kinetics, and the glucose-potentiated arginine test (GPA) to measure insulin secretory capacity, methods not
previously used in SA adolescents. We have assembled a highly experienced, multi-institutional (CNMC, CHOP, NIH),
and multi-disciplinary team with a track record of successful collaboration, to perform a cross-sectional study of 12-21
year old adolescents and young adults of SA ancestry (n=50), BMI ≥ 85%ile, compared to adolescents of European
ancestry (White) (n=50) and African American (AA) ancestry (n=50) of comparable age, sex, and BMI %ile. AA
individuals are known to also have increased cardiometabolic risk but have decreased visceral adiposity, making them a
unique comparison group. Aims: 1. To examine ancestry-related differences in body fat distribution (by MRI/MRS), FFA
flux (by 3-hour oral glucose tolerance test and Minimal Model of fatty acid kinetics), and to compare the relationships
between visceral adiposity and FFA flux among ancestral groups. 2. To examine ancestry-related differences in β-cell
insulin secretory capacity (by GPA), and compare the relationship between FFA flux and insulin secretory capacity
among groups. 3. To compare CVD and T2DM risk factors and vascular end organ injury (aortic pulse wave velocity)
among the three groups, and test for ancestry-related differences in the relationships between FFA flux and
cardiometabolic risk profile. Exploratory Aim: to compare adipocyte-derived exosomal microRNAs involved in insulin
signaling among the groups, and measure their association with β-cell insulin secretory capacity, for hypothesis
generation. Thus, this proposal will investigate whether associations between ectopic fat, FFA flux, and β-cell secretion
vary by ancestry to impact cardiometabolic risk, with the expectation that this may eventually lead to ancestry-specific
treatment options.
项目总结/摘要
南亚人(SA)是美国增长最快的主要种族群体,2型糖尿病(T2 DM)的发病率也较高,
与欧洲人和非洲人相比,体重指数(BMI)相对较低时的心血管疾病(CVD)风险
祖先这种心脏代谢风险增加的潜在机制仍不明确。我们将提交这份
响应NIH项目公告(PA-17-021)的研究提案,该公告要求提出解决健康问题的提案
NIDDK疾病的差异。SA美国人的心脏代谢风险增加代表了一个研究不足,
不同的风险大多数成年人,在美国以外进行的相关研究表明,SA具有较高的体脂百分比,
内脏肥胖和腹部肥胖的比例高于其他种族。这些研究还发现,
增加胰岛素抵抗和血脂异常以及减少胰岛素介导的葡萄糖处置(相反
与内脏脂肪成比例)和SA成人中的β细胞功能。我们建议研究SA青少年,以阐明
早期机械变化导致心脏代谢风险增加。鉴于SA独特的脂肪分布,我们
建议定义异位脂肪沉积,并检测SA青少年脂肪代谢和β细胞胰岛素分泌的改变
我们将使用尖端的创新技术,包括MRI/MRS,游离脂肪酸的数学建模,
酸(FFA)动力学和葡萄糖增强精氨酸试验(GPA)测量胰岛素分泌能力,方法不
曾用于青少年。我们已经组建了一个经验丰富的,多机构(CNMC,CHOP,NIH),
和多学科团队,具有成功合作的记录,进行12-21的横断面研究
SA血统的10岁青少年和年轻成年人(n=50),BMI ≥ 85%ile,与欧洲青少年相比,
年龄、性别和BMI百分比相似的血统(白色)(n =50)和非裔美国人(AA)(n=50)。AA
已知个体也具有增加的心脏代谢风险,但具有降低的内脏肥胖,使其成为
独特的对照组。目的:1.为了检查与祖先相关的体脂分布差异(通过MRI/MRS),FFA
通过3小时口服葡萄糖耐量试验和脂肪酸动力学最小模型,并比较它们之间的关系
内脏肥胖和FFA之间的关系2.为了检查β细胞中与祖先相关的差异,
胰岛素分泌能力(GPA),并比较FFA通量与胰岛素分泌能力的关系
在群体之间。3.比较CVD和T2 DM风险因素与血管终末器官损伤(主动脉脉搏波速度)
在三组之间,并测试FFA通量与
心脏代谢风险特征。探索性目的:比较脂肪细胞来源的外泌体microRNA参与胰岛素
信号传导,并测量其与β细胞胰岛素分泌能力的相关性,用于假设
一代因此,本研究将探讨异位脂肪、FFA通量和β细胞分泌之间的关系,
不同的祖先,以影响心脏代谢的风险,与预期,这可能最终导致祖先特异性
治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHEELA NATESH MAGGE其他文献
SHEELA NATESH MAGGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHEELA NATESH MAGGE', 18)}}的其他基金
The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes
优先研究:从预测到预防青少年发病的 2 型糖尿病
- 批准号:
10583291 - 财政年份:2023
- 资助金额:
$ 66万 - 项目类别:
Cardiometabolic Health in Adolescents of South Asian Ancestry - the CHAriSmA study
南亚血统青少年的心脏代谢健康 - CHARiSmA 研究
- 批准号:
10337807 - 财政年份:2018
- 资助金额:
$ 66万 - 项目类别:
Cardiometabolic Health in Adolescents of South Asian Ancestry - the CHAriSmA study
南亚血统青少年的心脏代谢健康 - CHARiSmA 研究
- 批准号:
10428356 - 财政年份:2018
- 资助金额:
$ 66万 - 项目类别:
Cardiometabolic Health in Adolescents of South Asian Ancestry - the CHAriSmA study
南亚血统青少年的心脏代谢健康 - CHARiSmA 研究
- 批准号:
9980384 - 财政年份:2018
- 资助金额:
$ 66万 - 项目类别:
Dyslipidemia and CV Risk Factors in Pediatric Obesity and Type 2 Diabetes
儿童肥胖和 2 型糖尿病中的血脂异常和心血管危险因素
- 批准号:
7299340 - 财政年份:2007
- 资助金额:
$ 66万 - 项目类别:
Dyslipidemia and CV Risk Factors in Pediatric Obesity and Type 2 Diabetes
儿童肥胖和 2 型糖尿病中的血脂异常和心血管危险因素
- 批准号:
7492896 - 财政年份:2007
- 资助金额:
$ 66万 - 项目类别:
Dyslipidemia and CV Risk Factors in Pediatric Obesity and Type 2 Diabetes
儿童肥胖和 2 型糖尿病中的血脂异常和心血管危险因素
- 批准号:
7623446 - 财政年份:2007
- 资助金额:
$ 66万 - 项目类别:
Dyslipidemia and CV Risk Factors in Pediatric Obesity and Type 2 Diabetes
儿童肥胖和 2 型糖尿病中的血脂异常和心血管危险因素
- 批准号:
7857956 - 财政年份:2007
- 资助金额:
$ 66万 - 项目类别:
GLUCOSE TOLERANCE AND INSULIN SENSITIVITY IN OBESE SIBLINGS OF TYPE 2 DIABETICS
2 型糖尿病肥胖兄弟姐妹的葡萄糖耐量和胰岛素敏感性
- 批准号:
7207752 - 财政年份:2005
- 资助金额:
$ 66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 66万 - 项目类别:
Research Grant